Latijnhouwers M A, Bergers M, Kuijpers A L, van der Vleuten C J, Dijkman H, van de Kerkhof P C, Schalkwijk J
Department of Dermatology, University Hospital Nijmegen, The Netherlands.
Acta Derm Venereol. 1998 Sep;78(5):331-4. doi: 10.1080/000155598442980.
Tenascin-C is an extracellular matrix glycoprotein that is markedly upregulated in the dermis of psoriatic skin. In this study, we have addressed the question whether the presence of tenascin-C in the lesion or in serum is a marker for disease activity. Immunohistochemical staining of tenascin-C before and after treatment with different topical and systemic medication showed that tenascin-C remained abundant after clinical remission of lesions, indicating that downregulation of tenascin-C to normal values is a slow process. By using a sensitive enzyme-linked immunosorbent assay to measure levels of serum tenascin-C in psoriatic patients and unaffected individuals, we found that tenascin-C levels in most patients were within the normal range. Moreover, tenascin-C values did not correlate with disease activity. We conclude that tenascin-C is not useful as a marker for disease activity in psoriasis.
腱生蛋白-C是一种细胞外基质糖蛋白,在银屑病皮肤的真皮中显著上调。在本研究中,我们探讨了病变部位或血清中腱生蛋白-C的存在是否为疾病活动的标志物这一问题。用不同局部和全身药物治疗前后对腱生蛋白-C进行免疫组织化学染色显示,病变临床缓解后腱生蛋白-C仍然大量存在,这表明腱生蛋白-C下调至正常水平是一个缓慢的过程。通过使用灵敏的酶联免疫吸附测定法测量银屑病患者和未受影响个体血清中腱生蛋白-C的水平,我们发现大多数患者的腱生蛋白-C水平在正常范围内。此外,腱生蛋白-C值与疾病活动无关。我们得出结论,腱生蛋白-C作为银屑病疾病活动的标志物并无用处。